Skip to main content
Clinical Trials/NCT03714750
NCT03714750
Completed
Not Applicable

Treatment of Coronary Bifurcation Lesions: a Non-inferiority, Randomized, Controlled Procedural Outcomes Trial Comparing Reverse T and Protrusion Versus Double-kissing and Crush Stenting

Tommaso Gori1 site in 1 country50 target enrollmentOctober 30, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Tommaso Gori
Enrollment
50
Locations
1
Primary Endpoint
Stent Expansion in the side branch (defined as the vessel which received the first stent)
Status
Completed
Last Updated
last year

Overview

Brief Summary

Treatment of bifurcation coronary lesions may be challenging, and the best technique to be used in these settings remains to be established. While a single stent strategy is simpler and has been often encouraged, a number of studies show that the use of modern stent implantation techniques may bring some advantages in terms of target lesion failure during longer follow-up. Further, single-stent procedures are not possible at all in some settings, for instance when both main and side branch have similar diameters and present both relevant disease, particularly when the angle between the vessels is lower than 70°. Recent randomized data demonstrate the superiority of the technique called double kissing and crush (DK-Crush) over provisional stenting in this setting. The DK-Crush technique is however cumbersome, time-consuming and requires very experienced operators. The investigators therefore plan to undertake a randomized study comparing a novel interventional technique against DK-crush in the setting of true bifurcation lesions (Medina lesions type 1,1,1 or 0,1,1).

Registry
clinicaltrials.gov
Start Date
October 30, 2018
End Date
April 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

Tommaso Gori

Prof. Dr. Tommaso Gori, PhD

Johannes Gutenberg University Mainz

Eligibility Criteria

Inclusion Criteria

  • Patients must meet all of the inclusion criteria:
  • Documented heart team (as per guidelines) decision for revascularization via PCI
  • Planned percutaneous coronary intervention (PCI) for a bifurcation stenosis with both branches \>2.5mm and with a stenosis \>50% and clinical indication to percutaneous intervention, including:
  • Ischemic symptoms, OR
  • Positive non-invasive imaging for ischemia, OR
  • Positive Flow Fractional Reserve (FFR), OR
  • mean lumen area (MLA) \<6mm\^2 for the left main or \<4mm\^2 for epicardial vessels as assessed by intracoronary imaging (IVUS, OCT)
  • Vessel diameter ≤5.00mm
  • True bifurcation lesion type 1,1,1 or 0,1,1
  • Patient ≥18 years old

Exclusion Criteria

  • Cardiogenic shock
  • Trifurcation if all vessels are ≥2.75mm diameter
  • Either bifurcation vessel not suitable for stenting
  • History of stenting in target bifurcation lesion
  • Participation in another investigational drug or device study
  • Patient unable to give informed consent
  • Women of child-bearing potential or lactating
  • In-stent restenosis

Outcomes

Primary Outcomes

Stent Expansion in the side branch (defined as the vessel which received the first stent)

Time Frame: through study completion, an average of 2 hours

Ratio of the minimum stent area of the side branch and the maximum stent area of the side branch

Secondary Outcomes

  • use of coronary wires(through study completion, an average of 2 hours)
  • fluoroscopy time(through study completion, an average of 2 hours)
  • procedural time(through study completion, an average of 2 hours)
  • protocol success(through study completion, an average of 2 hours)
  • Min. lumen Diameter in main branch(through study completion, an average of 2 hours)
  • Percentage of Stenosis in main branch(through study completion, an average of 2 hours)
  • Min. lumen Diameter in side branch(through study completion, an average of 2 hours)
  • Percentage of Stenosis in side branch(through study completion, an average of 2 hours)
  • Procedural success(through study completion, an average of 2 days)

Study Sites (1)

Loading locations...

Similar Trials